Newmont Corporation (LON:0R28)

London flag London · Delayed Price · Currency is GBP · Price in USD
62.06
-0.94 (-1.49%)
At close: Jul 31, 2025
-1.49%
Market Cap51.90B
Revenue (ttm)15.02B
Net Income (ttm)4.58B
Shares Outn/a
EPS (ttm)4.05
PE Ratio11.33
Forward PE14.52
Dividend0.77 (1.24%)
Ex-Dividend DateMay 27, 2025
Volume35,449
Average Volume84,886
Open62.70
Previous Close63.00
Day's Range61.80 - 62.95
52-Week Range36.75 - 66.53
Beta0.35
RSI56.13
Earnings DateJul 24, 2025

About Revance Therapeutics

Newmont Corporation engages in the production and exploration of gold properties. It also explores for copper, silver, zinc, lead, and other metals. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, Papua New Guinea, Ecuador, Fiji, and Ghana, and internationally. Newmont Corporation was founded in 1916 and is headquartered in Denver, Colorado. [Read more]

Industry Gold
Sector Materials
Founded 1916
Employees 22,200
Stock Exchange London Stock Exchange
Ticker Symbol 0R28
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.